Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Rocket Pharmaceuticals Inc.
Headquarters: Cranbury, NJ, United States of America
Website: https://rocketpharma.com/
Year Founded: 2015
Status: Public
Industry Sector: HealthTechnology
CEO: Gaurav D. Shah, MD
Number Of Employees: 299
Enterprise Value: $844,895,707
PE Ratio: -2.03
Exchange/Ticker 1: NASDAQ:RCKT
Exchange/Ticker 2: N/A
Latest Market Cap: $592,862,784
BioCentury | Dec 14, 2024
Finance
Data spells money for a quintet of biotechs
NewAmsterdam’s CETP readout leads to week’s largest follow-on
BioCentury | Jun 5, 2024
Data Byte
15 PDUFA dates on FDA’s roster in June
Upcoming decisions include HER3 ADC from Daiichi-Merck and full approval for Sarepta’s DMD gene therapy
BioCentury | Mar 27, 2024
Management Tracks
Rocket names Mirati vet Ondrey CFO
Plus: Syed Rizvi joins Poseida as CMO, and updates from Tvardi, Echosens and Bicara
BioCentury | Oct 2, 2023
Regulation
Oct. 2 Quick Takes: Takeda withdrawing Exkivity after confirmatory miss
Plus: Novartis’ iptacopan shows benefit in IgA nephropathy and updates from Mirum, Lexeo, Rocket, Lilly, Syndax, SAB, Amicus and Pneumagen
BioCentury | Sep 14, 2023
Regulation
Sept. 13 Quick Takes: Madrigal gets March PDUFA date for NASH therapy
Plus: Rocket parlays gene therapy update into $175M raise and updates from DalCor, Mironid, Crinetics, Shionogi, Hasten, Dewpoint and Orchid
BioCentury | Apr 6, 2023
Management Tracks
After leading CinCor to exit, de Garidel finds next CEO role at Abivax
Plus: INKEF’s Bulthuis joins Syncona and updates from Rocket, NGM, SparingVision, Walden and more
BioCentury | Dec 20, 2022
Management Tracks
MorphoSys’ CFO Lee leaving
Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx
BioCentury | Nov 2, 2022
Management Tracks
Cox to head digital health at Pfizer
Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more
BioCentury | Oct 19, 2022
Management Tracks
New chairs at SomaLogic, Anjarium
Plus Dechamps becomes CEO at Bioxodes, and updates from Abalos, M2Gen and Orion
Items per page:
1 - 10 of 32